Speaker Profile

Partner, Canaan

Biography
Julie Grant leads investments and company formation efforts in biopharma and digital health companies that tangibly improve patient care. Since joining Canaan in 2013, Julie has incubated, financed, and supported investments in multiple new biopharmaceutical companies including Nocion, Protagonist (PTGX), Cellular Research (Acquired by Becton Dickinson), Dermira (DERM), Labrys Biologics, CytomX (CTMX), Unchained Labs, Chrono Therapeutics, Genome Medical, Glooko, Vineti and Truveris. Prior to joining Canaan, Julie worked at Genentech bringing new oncology products to market in roles spanning business development, cross functional management and commercial. Julie served on the board of the Biden Cancer Initiative and co-chaired the IT advisory board for Planned Parenthood Northern California.


 Session Abstract – PMWC Silicon Valley


VC activity is booming in the healthcare sector. Point in case, investments have reached record-breaking numbers, including in the AI/ML field. This panel will discuss the future of the investment sector, how investments in AI/ML are shaping healthcare, and what to expect in the years to come.